GMP allows the manufacturing and exporting of GMP-produced medical cannabis products.
Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, today announced its wholly-owned subsidiary Tilray Portugal, Unipessoal Lda. has received a Good Manufacturing Practice certification in accordance with European Union standards, for its manufacturing facility in Cantanhede, Portugal. The GMP certification was issued by Infarmed, the Portuguese National Authority of Medicines and Health Products which provides end-to-end GMP certification for Tilray's current operations in Portugal.
Our third GMP certification will enable us to manufacture more products at our facility and export a greater range of medical products to international patients, partners and markets.Sascha Mielcarek, Tilray's Managing Director in Europe.
This is the third GMP certification for Tilray Portugal, which allows the facility to manufacture medical cannabis extracts in-house and export GMP-produced finished medical cannabis products, both dried flower and oil, from Portugal throughout European Union and other international markets with legal medical cannabis regulations. Further, the additional certification authorizes Tilray to manufacture bulk extracts on-site to sell as cannabis API and provides additional quality control lab capacity to further advance the Company's ability for product innovation and research.
"This is an important milestone for our strategic growth in the international medical cannabis market," says Sascha Mielcarek, Tilray's Managing Director in Europe. " As demand increases around the world and more legal medical cannabis markets emerge, Tilray's EU campus is ready to serve more partners and patients across the EU and other international medical markets."
To learn more about Tilray Inc, visit the company HQ here.
Disclaimer: Past performance is not an indicator of future performance.
Get the Latest Marijuana News &
Content in your Inbox!
All your support helps The Green Fund keep writing content for all you
marijuana enthusiasts and potential pot stock investors